Showing results (831-840 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|January 25, 2014
Connectivity-based approaches in stroke and recovery of functionChristian Grefkes, Gereon R Fink
The Lancet. Neurology|May 23, 2014
Long-term cerebral consequences of sepsisCatherine N Widmann, Michael T Heneka
The Lancet. Neurology|August 22, 2020
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Sandro Romanzetti, et al.
The Lancet. Neurology|August 22, 2020
Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort studyHerm J Lamberink, Willem M Otte, Ingmar Blümcke, et al.
The Lancet. Neurology|April 24, 2021
Advances in neuroimaging to improve care in sickle cell diseaseLori C Jordan, Michael R DeBaun, Manus J Donahue
The Lancet. Neurology|April 30, 2023
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trialYuesong Pan, Xia Meng, Baoshi Yuan, et al.
The Lancet. Neurology|September 11, 2007
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trialNicholas A Di Prospero, Angela Baker, Neal Jeffries, et al.
The Lancet. Neurology|June 21, 2008
Autologous haematopoietic stem-cell transplantation in multiple sclerosisGianluigi Mancardi, Riccardo Saccardi
The Lancet. Neurology|June 21, 2008
CSF hypocretin-1 assessment in sleep and neurological disordersPatrice Bourgin, Jamie M Zeitzer, Emmanuel Mignot
The Lancet. Neurology|April 17, 2007
Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised studyKa Sing Wong, Christopher Chen, Ping Wing Ng, et al.
Pageof 199